Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AD/PD 2021 | Biomarker advances & key challenges in dementia

Michelle Canavan, MB, BCH, BAO, PhD, National University of Ireland, Galway, Ireland, describes the advances reported in the field of fluid-based and imaging biomarkers for the detection of vascular dementia as a key highlight from the AD/PD™ 2021 conference. She also discusses some of the major challenges facing the field of dementia research including the fact that dementia is rarely reported as a primary outcome in clinical trials. This interview took place during the AD/PD™ 2021 conference.

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.